SCHEMBL16770596

SCHEMBL16770596

CCCCOC1[C@H](OCCCC)C(COC(=O)c2ccccc2)O[C@@H](O)[C@H]1OCCCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
TNF P01375 1/20 0.46
ALDH1A1 P00352 4/20 0.44
TSHR P16473 6/20 0.43
TDP1 Q9NUW8 3/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
MAPK1 P28482 4/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
ESR1 P03372 1/20 0.41
CYP2D6 P10635 1/20 0.41
NR1H2 P55055 1/20 0.41
RNASEL Q05823 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP3A4 P08684 3/20 0.40
POLB P06746 3/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16378347 1.00 LMNA (0.47) LMNATNFALDH1A1TSHRTDP1
SCHEMBL16383651 0.92 MEN1 (0.47) LMNATNFALDH1A1TSHRTDP1
SCHEMBL17359607 0.88 LMNA (0.45) LMNATNFALDH1A1TSHRTDP1
SCHEMBL18239897 0.86 LMNA (0.47) LMNAALDH1A1TSHRTDP1L3MBTL1
SCHEMBL8271920 0.85 LGALS9 (0.41) LMNATNFALDH1A1TSHRTDP1
SCHEMBL15483270 0.83 PTPN1 (0.56) LMNATNFALDH1A1L3MBTL1MAPK1
SCHEMBL14817669 0.83 PTPN1 (0.56) LMNATNFALDH1A1L3MBTL1MAPK1
SCHEMBL10182633 0.83 PTPN1 (0.56) LMNATNFALDH1A1L3MBTL1MAPK1
SCHEMBL8271923 0.83 MEN1 (0.45) LMNAALDH1A1TSHRTDP1L3MBTL1
SCHEMBL18239780 0.82 LMNA (0.43) LMNAALDH1A1TSHRTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160144016-A1 SYNTHETIC OLIGOSACCHARIDES FOR P. AERUGINOSA VACCINE SYNGLYCO PHARMACEUTICALS, INC. (US) 2016-05-26 US disclosed
US-20150152129-A1 Synthetic Oligosaccharides for P. Aeruginosa Vaccine SYNGLYCO, INC. 2015-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150152129-A1 Synthetic Oligosaccharides for P. Aeruginosa Vaccine DDOST, FUT5, FUT6 LMNA 4591/4885TNF 533/4885ALDH1A1 4427/4885
US-20160144016-A1 SYNTHETIC OLIGOSACCHARIDES FOR P. AERUGINOSA VACCINE DDOST, FUT5, FUT6 LMNA 4591/4885TNF 533/4885ALDH1A1 4427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.